Resources

Medical professional

Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management.  Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.

 

Showing 271 to 280 of 352 resources

  • Scottish National Clinical Guidelines for the treatment of HCV in adults
    These guidelines, published by Health Improvement Scotland and NHS National Services Scotland, provide guidance to Health Board Area Drug and Therapeutics Committees on the recommended use of available hepatitis C drugs, taking into consideration Scottish Medicines Consortium guidance, clinical effectiveness and price.
    UK, Scotland Feb 2016 Other, Strategy & Planning PDF
  • Scottish Sexual Health and Blood Borne Virus Framework 2015 - 2020
    The Sexual Health and Blood Borne Virus Framework, published by the Scottish Government, drives hepatitis C strategy in Scotland. The 2011 - 2015 version of the Framework led to significant improvements in the way in which the virus was managed in Scotland, and the new incarnation of the Framework seeks to sustain and build upon this progress.
    UK, Scotland Sep 2015 Other, Strategy & Planning PDF
  • Sheffield Liver Disease Profile
    This document, produced by Public Health England, provides an overview of liver disease in Sheffield. It includes key facts on hepatitis C in Sheffield, as well as a section on 'Questions you should ask locally', which aims to improve local prioritisation and management of hepatitis C.
    UK, England, Yorkshire and the Humber Nov 2014 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK, 2016
    This resource, produced by Public Health England, provides an annual update on infections among people who inject drugs (PWIDs) in the UK. The report reveals that hepatitis C remains the most common blood-borne infection among PWIDs, and that approximately half (48%) of hepatitis C infections among PWIDs remain undiagnosed. Of those who were unaware of their infection, 22% reported that they had never been tested, and of those unaware but tested, 44% reported that their last test had been more than two years earlier.
    UK Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK, 2018
    This December 2019 update to the Shooting Up: Infections among people who inject drugs in the UK, produced by Public Health England, provides updated data to the end of 2018. The report says that there is early evidence for a reduction in chronic hepatitis C prevalence among injecting drug users, but that rates of new infection are unchanged, including amongst individuals who have recently started injecting.
    UK 20 Dec 2019 Reports & Research PDF
  • Shooting Up: infections among people who inject drugs in the UK, 2019
    Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.
    UK, England, Northern Ireland, Scotland, Wales 28 Jan 2021 Reports & Research PDF
  • Signposting the Way to Elimination by 2025
    The Hepatitis C Coalition is an umbrella group of leading clinicians, patient organisations, professional groups, industry and other interested parties committed to the reduction of morbidity and mortality associated with hepatitis C and its eventual elimination. This collaborative strategy builds on the release of the All-Party Parliamentary Group on Liver Health's 'Eliminating Hepatitis C in England' report and Public Health England's 'Hepatitis C in England: 2018 Report', with the aim of coordinating action by the key stakeholders involved in delivering elimination.
    England Reports & Research, Strategy & Planning PDF
  • Social Impact of HCV
    This presentation from Dr Rui Tato Marinho, Gastroenterologist at Lisbon Medical School, was first delivered at the 'HCV and Your Body' conference in Amsterdam in November 2014. It provides an overview of the physical, mental and social impact of hepatitis C, and covers issues such as stigma; homelessness; unemployment and loss of productivity.
    UK, Rest of World Nov 2014 Other, Reports & Research PDF
  • Standards for Local Surveillance and Follow Up of Hepatitis B and C
    These standards, produced by the Health Protection Agency in 2011, recognise that the detection and clinical management of hepatitis B and C can involve a number of health professionals, creating a diversity of clinical pathways. The development of the standards has also taken into account the fact that the prevalence of both hepatitis B and C varies markedly across the country and that current systems for the surveillance and follow up of cases also vary.
    UK 2011 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Staying Alive in Scotland: Strategies to Prevent Drug Deaths
    This updated toolkit, a partnership between the Scottish Government and Scottish Drugs Forum, updates the original report produced three years ago. The resource notes that DAA treatments for hepatitis C provide an opportunity to prevent drug-related deaths, but that opportunities to test for hepatitis C are being missed.
    Scotland 20 Dec 2019 Reports & Research PDF

Pages